Stroke Journal

JANUARY 30, 2025

Introduction:All-cause dementia remains a significant public health concern, with stroke recognized as a key risk factor. They had slightly higher systolic blood pressure, lower BMI, higher rates of comorbidities, and medication use (Table 1). Stroke, Volume 56, Issue Suppl_1 , Page AWP269-AWP269, February 1, 2025.

Dementia 40

Dementia Stroke Strokes Blood Pressure 40

Cardiology Update

JANUARY 24, 2024

Metabolic risks, including high systolic blood pressure, high LDL cholesterol, high BMI, high fasting plasma glucose, and kidney dysfunction, contribute substantially to age-standardized CVD disability-adjusted life years (DALYs). The findings have significant implications for clinical and public health practice and research.

Cardiovascular Disease 119

Cardiovascular Disease Research Blood Pressure Public Health 119

DAIC

MARCH 8, 2024

The estimated relative risk reduction of MACE was 20% vs placebo (HR 0.80 [95% CI: 0.72, 0.90] p 1,2 The reduction of MACE with Wegovy was not impacted by age, sex, race, ethnicity, baseline BMI, or level of renal function impairment. in patients randomized to Wegovy 2.4 mg and 36.4% of patients receiving placebo. 2 What is Wegovy?

Obesity 111

Obesity Heart Disease Heart Attack Heart attacks 111